United States · FDA National Drug Code directory
Lubiprostone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71205-831_4aed57d0-99d8-424e-a1c7-0cd8a31a66cf
- Product NDC
- 71205-831
- Form
- CAPSULE, GELATIN COATED
- Composition / generic term
- lubiprostone
- Labeler
- Proficient Rx LP
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20230101
- Source listing expiry
- 20261231
Source-listed ingredients
- LUBIPROSTONE — 8 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, GELATIN COATED in 1 BOTTLE (71205-831-00) · 71205-831-00
- 1000 CAPSULE, GELATIN COATED in 1 BOTTLE (71205-831-11) · 71205-831-11
- 30 CAPSULE, GELATIN COATED in 1 BOTTLE (71205-831-30) · 71205-831-30
- 500 CAPSULE, GELATIN COATED in 1 BOTTLE (71205-831-55) · 71205-831-55
- 60 CAPSULE, GELATIN COATED in 1 BOTTLE (71205-831-60) · 71205-831-60
- 240 CAPSULE, GELATIN COATED in 1 BOTTLE (71205-831-64) · 71205-831-64
- 270 CAPSULE, GELATIN COATED in 1 BOTTLE (71205-831-67) · 71205-831-67
- 120 CAPSULE, GELATIN COATED in 1 BOTTLE (71205-831-72) · 71205-831-72
- 180 CAPSULE, GELATIN COATED in 1 BOTTLE (71205-831-78) · 71205-831-78
- 90 CAPSULE, GELATIN COATED in 1 BOTTLE (71205-831-90) · 71205-831-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →